136 related articles for article (PubMed ID: 33402463)
1. Correlation Between Onco-suppressors PTEN and NM23 and Clinical Outcome in Patients With T1 Breast Cancer.
Izzo L; Messineo D; DI Cello P; Nicolanti V; Sterpetti A; Izzo S; Izzo P
In Vivo; 2021; 35(1):169-174. PubMed ID: 33402463
[TBL] [Abstract][Full Text] [Related]
2. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
3. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of survivin and nm23 and the relationship among the expressions and the axillary lymph node metastasis in breast cancer].
Mao J; Hai J; Shu HP; Wu YH; Ou HY; Luo SY; Wang SM
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):312-4, 334. PubMed ID: 16045021
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of PTEN and nm23 in the metastasis of gallbladder cancer].
Zheng CL; Wen JF; Huang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):46-8. PubMed ID: 15875318
[TBL] [Abstract][Full Text] [Related]
6. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
Heimann R; Lan F; McBride R; Hellman S
Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
8. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
[TBL] [Abstract][Full Text] [Related]
9. Nm23 gene product expression in invasive breast cancer--immunohistochemical analysis and clinicopathological correlation.
Belev B; Alerić I; Vrbanec D; Petrovecki M; Unusic J; Jakić-Razumović J
Acta Oncol; 2002; 41(4):355-61. PubMed ID: 12234027
[TBL] [Abstract][Full Text] [Related]
10. Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein.
Han S; Yun IJ; Noh DY; Choe KJ; Song SY; Chi JG
J Surg Oncol; 1997 May; 65(1):22-7. PubMed ID: 9179263
[TBL] [Abstract][Full Text] [Related]
11. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
Liu H; Mao H; Fu X
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092
[TBL] [Abstract][Full Text] [Related]
12. Lack of prognostic significance of nm23 expression in human primary breast cancer.
Göhring UJ; Eustermann I; Becker M; Neuhaus W; Rein DT; Schöndorf T
Oncol Rep; 2002; 9(6):1205-8. PubMed ID: 12375020
[TBL] [Abstract][Full Text] [Related]
13. The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer.
Heimann R; Ferguson DJ; Hellman S
Cancer Res; 1998 Jul; 58(13):2766-71. PubMed ID: 9661889
[TBL] [Abstract][Full Text] [Related]
14. [Expression of sialylated carbohydrate antigens and nm23-H1 gene in prognosis of breast cancer].
Ding KF; Wu JM
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 33(4):326-30, 339. PubMed ID: 15269984
[TBL] [Abstract][Full Text] [Related]
15. nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy.
Sauer T; Furu I; Beraki K; Jebsen PW; Ormerod E; Naess O
Cancer; 1998 Apr; 84(2):109-14. PubMed ID: 9570214
[TBL] [Abstract][Full Text] [Related]
16. Nm23 expression in breast ductal carcinomas: a ten year follow-up study in a uniform group of node-negative breast cancer patients.
Kapranos N; Karaiossifidi H; Kouri E; Vasilaros S
Anticancer Res; 1996; 16(6C):3987-90. PubMed ID: 9042324
[TBL] [Abstract][Full Text] [Related]
17. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.
Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G
Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878
[TBL] [Abstract][Full Text] [Related]
18. [Low expression of nm23-H1 mRNA and its protein in breast cancer].
Guo W; Wang Y; Zhuang X; Bai Y; Zhang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):91-3. PubMed ID: 10751528
[TBL] [Abstract][Full Text] [Related]
19. Loss of nm23 expression predicts distal metastases and poorer survival for breast cancer.
Mao H; Liu H; Fu X; Fang Z; Abrams J; Worsham MJ
Int J Oncol; 2001 Mar; 18(3):587-91. PubMed ID: 11179491
[TBL] [Abstract][Full Text] [Related]
20. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
Tannapfel A; Köckerling F; Katalinic A; Wittekind C
Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
